This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Lg Life Sciences, Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Tae Ho Heo: Innovator in Isoxazoline Derivatives
Introduction
Tae Ho Heo is a notable inventor based in South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of isoxazoline derivatives. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Tae Ho Heo holds a patent for an isoxazoline derivative and a novel process for its preparation. This invention relates to an isoxazoline derivative featuring a cyclic carboxylic acid hemiketal moiety, which is utilized as a caspase inhibitor. The patent outlines a process for preparing this compound and includes a pharmaceutical composition that incorporates it.
Career Highlights
Throughout his career, Tae Ho Heo has demonstrated a commitment to advancing pharmaceutical science. His research has the potential to impact therapeutic strategies significantly. Although he currently holds no patents, his work in the field is noteworthy.
Collaborations
Tae Ho Heo has collaborated with esteemed colleagues, including Hyun Ik Shin and Hyeong Wook Choi. These partnerships have contributed to the development of innovative solutions in their shared field of expertise.
Conclusion
Tae Ho Heo is an influential figure in the realm of pharmaceutical innovation, particularly in the area of isoxazoline derivatives. His contributions, although currently limited in patent count, reflect a dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile